Novo Nordisk, citing strong Wegovy demand, doubles 2025 sales target for obesity franchise | Fierce Pharma
Investor presentation Citi's Swiss Healthcare Investor ... - Novo Nordisk
Novo Nordisk Investor Portal - About the portal
ar_001.jpg
Investors
Newly Released: Novo Nordisk Publishes Integrated 2019 Annua
Annual Report 2021
Contact our Novo Nordisk Investor Relations team
Novo Nordisk A/S purchases B shares worth DKK 3,582 million from Novo Holdings A/S under the 2022 share repurchase programme
company announcement
Financial results and events overview - Novo Nordisk
Contact our Novo Nordisk Investor Relations team
Annual Report 2007 - Novo Nordisk
Share and ownership structure of Novo Nordisk
f6k_01.jpg
Novo Nordisk Prize Interview 2022 on Vimeo
Contact our Novo Nordisk Investor Relations team
Contact our Novo Nordisk Investor Relations team
Novo Nordisk Investor Relations Material - Quartr
